| Target Price consensus revisions : last 18 months |
|
|
|
| Evolution of the average goal on BIOCRYST PHARMACEUTICALS, |
|
|
|
Data source :
© 2015 Thomson Reuters |
|
|
|
|
|
| Mean consensus |
OUTPERFORM |
| Number of Analysts |
13 |
| Average target price |
17,5 $ |
| Last Close Price |
10,7 $ |
| Spread / Highest target |
124% |
| Spread / Average Target |
63% |
| Spread / Lowest Target |
-25% |
|
|
|
|
|
| Consensus revision (last 18 months) |
|
|
|
|
